Health Care [ 8/12 ] | Biotechnology [ 32/76 ]
NASDAQ | Common Stock
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.
The company offers inflammatory response to fend off infections and repair damaged tissue in the body.
It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.
The company is headquartered in Denver, Colorado.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | -7.43 M Decreased by -292.49% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -3.67 M Decreased by -306.76% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -5.26 M Decreased by -424.10% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -19.21 M Decreased by -1.64 K% | Decreased by N/A% - |
| Sep 30, 22 | 0.00 Decreased by N/A% | -1.89 M Decreased by -77.65% | Decreased by N/A% - |
| Jun 30, 22 | 0.00 - | -902.00 K - | Decreased by N/A% - |
| Mar 31, 22 | 0.00 - | -1.00 M - | Decreased by N/A% - |
| Jun 30, 21 | N/A - | -1.11 M - | - - |